ZCY.F CRYO-CELL INTL DL-01

Healthcare Health Care Providers & Services Frankfurt Exchange
4.28 EUR
Close of Nov 12, 2026
2.32 4.50
Market cap
EUR 34.5M
P/E
-
P/B
9.72x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to May 2026.

Is ZCY.F undervalued?

Graham number

The Graham number of CRYO-CELL INTL DL-01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CRYO-CELL INTL DL-01 fundamental analysis

No fundamental analysis for CRYO-CELL INTL DL-01 yet.

CRYO-CELL INTL DL-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CRYO-CELL INTL DL-01

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umb…

Full company profile